Fifth Third Wealth Advisors LLC Purchases 1,981 Shares of Danaher Co. (NYSE:DHR)

Fifth Third Wealth Advisors LLC lifted its position in Danaher Co. (NYSE:DHRFree Report) by 123.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,584 shares of the conglomerate’s stock after buying an additional 1,981 shares during the quarter. Fifth Third Wealth Advisors LLC’s holdings in Danaher were worth $895,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Cary Street Partners Investment Advisory LLC lifted its holdings in Danaher by 20.2% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 9,128 shares of the conglomerate’s stock worth $2,112,000 after purchasing an additional 1,533 shares during the last quarter. First Citizens Bank & Trust Co. lifted its holdings in Danaher by 0.6% in the 4th quarter. First Citizens Bank & Trust Co. now owns 26,611 shares of the conglomerate’s stock worth $6,156,000 after purchasing an additional 149 shares during the last quarter. Cercano Management LLC lifted its holdings in Danaher by 11.4% in the 4th quarter. Cercano Management LLC now owns 202,569 shares of the conglomerate’s stock worth $46,862,000 after purchasing an additional 20,715 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Danaher by 48.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 296,996 shares of the conglomerate’s stock worth $68,707,000 after purchasing an additional 96,395 shares during the last quarter. Finally, Caden Capital Partners LP lifted its holdings in Danaher by 12.4% in the 4th quarter. Caden Capital Partners LP now owns 139,068 shares of the conglomerate’s stock worth $32,172,000 after purchasing an additional 15,313 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Barclays boosted their target price on Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 24th. Robert W. Baird upped their price target on Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a report on Wednesday, April 24th. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a report on Tuesday. TD Cowen upped their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Finally, Bank of America upped their price target on Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a report on Wednesday, April 24th. Six equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $269.29.

Read Our Latest Analysis on Danaher

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 4,000 shares of the stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $250.01, for a total transaction of $1,000,040.00. Following the sale, the senior vice president now owns 29,830 shares in the company, valued at $7,457,798.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Rainer Blair sold 47,175 shares of the firm’s stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total value of $11,756,953.50. Following the transaction, the chief executive officer now owns 115,995 shares in the company, valued at $28,908,273.90. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Brian W. Ellis sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $250.01, for a total value of $1,000,040.00. Following the completion of the transaction, the senior vice president now owns 29,830 shares in the company, valued at approximately $7,457,798.30. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 148,783 shares of company stock worth $37,536,717. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

NYSE:DHR traded down $1.79 during trading hours on Thursday, reaching $251.80. The company had a trading volume of 2,409,236 shares, compared to its average volume of 2,835,434. The stock has a 50-day moving average of $255.36 and a two-hundred day moving average of $246.19. Danaher Co. has a one year low of $182.09 and a one year high of $269.11. The firm has a market capitalization of $186.51 billion, a PE ratio of 42.61, a PEG ratio of 3.89 and a beta of 0.85. The company has a quick ratio of 1.51, a current ratio of 1.85 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.62 billion. During the same period in the prior year, the business posted $2.36 earnings per share. The business’s revenue was down 2.6% compared to the same quarter last year. Analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.43%. The ex-dividend date is Friday, June 28th. Danaher’s payout ratio is presently 18.31%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.